Conference Coverage

MONARCH 3: Abemaciclib plus AI boosts PFS in HR+/HER2- breast cancer

Publish date: September 19, 2017

 

AT ESMO 2017

Pages

Recommended Reading

Annual mammograms from age 40 linked with greatest reductions in mortality
Breast Cancer ICYMI
2017 Update on female sexual dysfunction
Breast Cancer ICYMI
FDA expands approval of fulvestrant for HR+/HER2– advanced breast cancer
Breast Cancer ICYMI
Focus on lifestyle to manage menopause symptoms after breast cancer
Breast Cancer ICYMI
FDA clears first 2D mammography device with patient-controlled compression
Breast Cancer ICYMI
Assessing a multidisciplinary survivorship program in a group of predominantly Hispanic women with breast cancer
Breast Cancer ICYMI
An ASCO 2017 recap: significant advances continue
Breast Cancer ICYMI
Ten-year outcomes support skipping axillary lymph node dissection with positive sentinel nodes
Breast Cancer ICYMI
Surgeons strongly influenced chances of contralateral prophylactic mastectomy
Breast Cancer ICYMI
LORELEI sings praises of neoadjuvant taselisib/letrozole in ER+/HER2– breast cancer
Breast Cancer ICYMI